ABSTRACT
INTRODUCTION
cause of cancer and third leading cause of death among cancer worldwide, with incidence about 14.7% and 4.9% per 100.000 patients, respectively.
1,2 Approximately 70-90% HCC patients suffered from chronic liver disease or cirrhosis manifestations prior to HCC, with hepatitis B infection, hepatitis C infection, non-alcoholic and alcoholic fatty liver disease as the main causes. 2, 3 Treatment of choice in HCC depends on tumour size, number of lesions, patient's performance status, and liver functional reserve, that were presented in BCLC staging. 4, 5 During initial diagnosis, only 30% patients transplant, ablation therapy, and surgical resection, whereas others were not suitable for curative therapy so they had to underwent palliative treatment, such as transarterial chemoembolization (TACE) and Sorafenib. 1, 6 TACE is treatment strategy that is recommended for HCC patients with intermediate stage, where there is large uninodular and multinodular HCC with preserved liver function (Child A/B), and without vascular invasion or extrahepatic dissemination. 5, 7 Rationalization of TACE in HCC is based on 2 vascularization. First, portal vein that gives nutrition to liver parenchyma, and second, hepatic artery that gives nutrition to the tumour with various stage of hypervascularization. Administration of transarterial cytotoxic drugs combined with arterial embolization will cause local cytotoxic effect and tumour ischemia. 1, 8 Response to TACE could be evaluated through the decreasing of tumour marker level, amount of intratumour necrotic area, and shrinking of tumour size and number of tumour lesions. These responses were associated with better survival. 5, 9 Although TACE has direct anti tumour effect, it can also cause complications such as increasing of transaminase serum level and negative changes in liver function, that probably caused by ischemic injury in liver and also tumour necrosis. 10, 11, 12 Alpha-fetoprotein (AFP) is protein from fetal component that is produced by fetal liver and gestasional sac during embryo period. Adult AFP normal level is < 20 ng/mL. High AFP serum level was found in 60-70% HCC patients, but was still normal in 15-30% patients. False positive results are usually found in many conditions such as pregnancy, liver cirrhosis, lung cancer, biliary cancer, gastric cancer, pancreatic cancer, testicular cancer, and drugs/alcohol abuse. 5, [13] [14] [15] [16] [17] [18] In this size, number of lesions, and AFP serum levels.
METHOD
We compiled secondary data from medical records in interventional radiology department and gastrohepatology outpatient clinic in Dr. Soetomo General Hospital, including all patients above 18 years old, who were diagnosed with HCC stage BCLC to June 2015 period. Diagnosis of HCC was based on European Association for The Study of The Liver (EASL) criteria, where there was classical lesion in 2 radiology imaging (CT-Scan/MRI/USG) or 1 radiology imaging, with elevation of AFP serum level > 400 liver biopsy. Exclusion criteria were: (1) Presence of liver decompensation signs and symptoms (ascites, active gastrointestinal bleeding, encephalopathy, liver failure); (2) Had been underwent resection therapy, ablation, transplant, or TACE; (3) Presence of severe illness Karnoffsky score < 50); (4) Presence of history of malignancy before HCC or HCC that has metastasized; (5) Presence of history of coronary heart disease, heart failure, or chronic renal failure. We criteria.
Data that were collected include age, sex, HCC aetiologies (hepatitis B and hepatitis C viral marker), BCLC staging, and chief complaint. Data of hemoglobin, leucocyte, trombocyte, AST, ALT, bilirubin, albumin, AFP, tumour size, and number of lesions that were collected were initial data (before session of TACE session, when patients came to the gastro-hepatology outpatient clinic. CT scan abdomen tumour diameter and if there was multiple tumour, diameter from all lesions.
TACE procedure was performed according to the standardised protocol and was performed by experienced interventionist in interventional radiology unit in Dr. Soetomo General Hospital Surabaya. TACE was performed percutaneously using Seldinger technique. After catheter 5 Fr was inserted into femoral of left and right hepatica arteries. After that, selective catheterization was performed to arteries that gave blood supply to the tumour. TACE was performed with combination suspension of chemotherapy drugs, that consisted of Doxorubicin 10-40 mg with or without carboplatin 450 mg mixed in 10 mL lipiodol, followed by embolization using gel foam. The procedure was complete if from contrast test result, (devascularization). Amount of chemotherapy drugs and lipiodol was given according to the number, location, and diameter of lesions.
Data were collected and analyzed using SPSS software version 20 Table 2 .
In this study, evaluation of TACE included tumour size, number of tumour lesions, and AFP level before 
DISCUSSION
cancer and third leading cause of death among cancer, worldwide, with high mortality rates.
1,2 TACE is the main palliative treatment of choice for HCC patients 5, 7 In one metaanalysis that included 18 randomised-controlled clinical trial, Camma et al, showed better survival in TACE group compared to the control group. 19 Chronic hepatitis B and hepatitis C infection are major risk factors of HCC, besides other causes, such as metabolic syndrome (obesity, diabetes mellitus), alcohol, toxin, drugs, and autoimmune. 20 In this study, the most common risk factor of HCC was hepatitis B infection. This was consistent with prior studies, where hepatitis B-associated HCC was mostly found in Asian, Africa, and Latin America Countries, whereas hepatitis C-associated HCC was mostly found in countries in Europe, North America, Japan, Mongolian, and Egypt. 21, 22, 23, 24 Male had higher risk for HCC, with ratio to female about 2-4:1. In this study, male HCC patients were more than female with ratio of about 3:1. Genetic susceptibility factors and hormonal factors, as well as smoking and alcohol drinking habits were believed as strong risk factors for HCC in male. 15, 20, [25] [26] [27] [28] [29] [30] Elevation of AFP level could reflect abnormal hepatocyte regeneration, so AFP was long used as marker to detect HCC. High AFP serum level was found in 60-70% HCC patients, but was still at normal level in 15-30% patients. 5, 13 For diagnosis, AFP level but in level 200 ng/mL, its sensitivity decreased to only 31, 32 In this study, we found 14 patients (22.9%) with AFP level < 200 ng/mL, 13 patients (21.3%) with AFP level 200-1000 ng/mL, and 34 patients (55.7%) with AFP level >1000 ng/mL. We used upper cut-off of 1000 because AFP level data in this study could not detect absolute amount higher than 1000 ng/mL. Survival is the main goal of TACE in HCC, but evaluation of tumour local response is also important to evaluate the effectiveness of TACE technique. Tumour local response evaluation with CTScan or MRI could be done in 1-3 months after TACE procedure. 1 In this study, we did not evaluate survival, but only tumour local response that we observed from tumour size, number of tumour lesions, and tumour marker level in 1 month post TACE. 33, 34, 35 Tumour technique or chemotherapy drugs and embolization, but were not evaluated in this study. 1 Large tumour size is a risk factor for tumour recurrence, although in this study, it was found that early tumour reccurency could also happen in small tumour, in resectable HCC. 36 In this study, there was tumour lesion in 1 month post TACE, with mean of about 1.76 cm and 2.33, respectively. These results were consistent with prior studies, where it was so rare to achieve complete response after TACE (0-4%), even tumour often adapted to the new angiogenesis. Therefore, in the next evaluation, usually increased size or number of tumour lesions was found. 35 In contrast, and number of tumour lesions post TACE, but in this study, evaluation was performed 1 week post TACE, where neoangiogenesis process had not increase compared to evaluation in 1 month post TACE. 37 Decrease of > 50% AFP level from initial level after locoregional therapy such as TACE and radioembolization, was reported to be useful in evaluate tumour response and survival, also in evaluating progressivity of lesion that could be seen through radiology examination.
18,33 AFP level also had been studied as prognostic predictor of resectable HCC. 2, 17 In this study, patients with AFP level >1000 ng/mL.
In this study, patients whose AFP level were > 1000 ng/mL pre-TACE were 34 patients, and this number decreased to 24 patients in 1 month post-TACE. Patients whose AFP level were 200-1000 ng/ mL pre-TACE were 13 and this increased to 24 patients in 1 month post-TACE, while 13 patients with AFP level < 200 ng/mL decreased to 12 patients in 1 month in one health center, with small sample size, short follow-up time (only 1 month) so it could not asses survival. The future studies with longer time of follow up, bigger sample size, and evaluation of survival are needed to achieve better results which can be applied in bigger population, especially in Indonesia.
CONCLUSION
From this study, it could be concluded that tumour increased in 1 month post TACE, whereas AFP level different. Therefore, the decision to perform TACE as to-risk ratio must be considered.
